In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a benzoyl benzenecarboperoxoate Drug Master File in Korea (benzoyl benzenecarboperoxoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of benzoyl benzenecarboperoxoate. The MFDS reviews the benzoyl benzenecarboperoxoate KDMF as part of the drug registration process and uses the information provided in the benzoyl benzenecarboperoxoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a benzoyl benzenecarboperoxoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their benzoyl benzenecarboperoxoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of benzoyl benzenecarboperoxoate suppliers with KDMF on PharmaCompass.